Amryt Pharmaceuticals Designated Activity CompanyUsage: Myalept treats leptin deficiency complications in patients with congenital or acquired generalized lipodystrophy, used alongside diet as replacement therapy. Not indicated for partial lipodystrophy, HIV-related lipodystrophy, or metabolic disease without confirmed generalized lipodystrophy.